Four Seasons Womens Health
2017
Rickety Lane
Tyler
75703
October 01, 2000
This was an open lable, pilot translational clinical pharmacology study of a brief (7 day) course of UFT, 300 mg/m²/day, in combination with leucovorin, 90 mg/day, in six patients with newly diagnosed advanced colorectal cancer.